Our long-term data demonstrate that laparoscopic RYGBP is a safe and effective operation for morbidly obese adolescents, in the proper setting. We advocate that surgical intervention be recommended for this population using the same NIH guidelines used for adults.
LGBRY can be done safely in patients over 60 years of age in an experienced bariatric program, even in patients with relatively high risk based on their comorbid conditions preoperatively. Resolution of associated comorbidities far exceeds that found with any other treatment modality.
We hereby demonstrate that the construction of GJ anastomosis with a 21-mm circular stapler is associated with a low stricture rate using our standardized technique. Strictures are amenable to balloon dilatation with subsequent long-term resolution of symptoms.
participating neonatal units within the network. 10 cases from each unit were included. These referred to term or preterm infants who required intravenous antibiotics for suspected or confirmed early onset sepsis with a minimum length of stay of 10 days. The data were analysed using SPSS 17.0. Results 15 units participated. 149 babies were recruited with a mean gestational age of 32+2 weeks. 91.3% of babies received intravenous benzyl penicillin and gentamicin as first line treatment. In 25% of cases there were prescribing issues regarding gentamicin. 20.1% received cefotaxime. 19.5% of babies underwent a lumbar puncture. 17.5% of babies received antifungal agents. In 15.4% of which as treatment. Conclusions The overall outcome was positive with prompt recognition of risk factors and initiation of treatment across all units. This unified policy promotes good quality of care. However, the percentage of prescribing issues regarding gentamicin was worryingly high. Hence, further studies and review of literature are required to evaluate the efficiency of our practice and to establish alternative choice of antibiotics.
PS-217
IMPACT OF THE NEW ALGORITHM FOR MANAGEMENT OF NEWBORNS WITH RESPECT TO RISK FOR EARLY-ONSET GBS DISEASEM García Díaz, T González Martínez, V García González, J GonzáLez García, B Fernández Martinez, C Pérez Mendez. Servicio de Pediatria, Hospital de Cabueñes, Gijon, Spain 10. 1136/archdischild-2014-307384.516 Background Guidelines for the prevention of perinatal group B streptococcal (GBS) disease were updated in 2010, including a revised algorithm for management of newborns with respect to risk for early-onset GBS disease (EOD-GBS). Aim To know the impact of this new algorithm on EOD-GBS evaluations, hospital admissions, and detection of EOD-GBS cases in a newborn unit. Methods Retrospective cohort study of infants of GBS-colonised mothers born at ≥36 weeks gestational age in two periods of time: from July to December 2010, and from July to December 2012. The following variables were analysed: gender, gestational age, chorioamnionitis, indication for and prescription of antibiotics to the mother, EOD-GBS evaluations, infant admission and outcome. Continuous data were compared by using t test; discrete data using chi square. Preventable fraction in the exposed (Pf e ) was used to quantify the impact or the new algorithm. Results One hundred and fifty-two neonates were included in 2010 and 130 in 2012. No significant differences between both groups were found regarding gender, gestational age, chorioamnionitis, obstetric care and antibiotic prophylaxis received by mothers. There were no cases of GBS infection in both periods. The new algorithm avoided 88% evaluations in EOD-GBS screening from 2010 to 2012 (Pf e = 0.88, 95% confidence interval [CI]: 0.39-0.96). The number of infants admitted for suspected EOD--GBS was reduced by 48.1% (Pf e : 0.481, 95% CI: -0.648-0.864). Conclusions Implementation of the 2010 algorithm resulted in a decrease of EOD-GBS evaluations and the number of newborn adm...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.